Leishmaniasis in Children: A Study
Part of Infections, Skin clinical trials.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 18 years old when diagnosed.
- They must have a confirmed diagnosis of leishmaniasis made by a doctor using standard criteria.
- You (the parent or guardian) must give written permission for them to join. If your child is old enough, they will also be asked if they agree.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people diagnosed with visceral leishmaniasis, a serious infection caused by a parasite. It aims to learn more about the condition and how it affects people in the Emilia-Romagna region.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This trial tests if oral medicines can treat cutaneous (skin) or mucosal leishmaniasis in people aged 60 and older. It compares two different pills to find a safer, easier option for elderly patients.
This study looks at how the immune system reacts to Leishmania infection and searches for new ways to diagnose the disease. It may help develop better tests for leishmaniasis.
This study follows children and teens with different stages of tuberculosis (TB) across Italy. It aims to learn more about how TB affects young people and improve care.
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
Hear when a new Leishmania Infantum Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.